18 results on '"Pellegrini, Marco"'
Search Results
2. Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study
3. Deep Anterior Lamellar Keratoplasty: Current Status and Future Directions
4. In Vivo Confocal Microscopy Morphometric Analysis of Meibomian Glands in Patients With Graves Ophthalmopathy
5. Longitudinal Analysis of Infrared Meibography in Patients Undergoing Hematopoietic Stem Cell Transplantation
6. Reply
7. In Vivo Confocal Microscopy Automated Morphometric Analysis of Corneal Subbasal Nerve Plexus in Patients With Dry Eye Treated With Different Sources of Homologous Serum Eye Drops
8. Efficacy of Omega-3 Fatty Acid Supplementation for Treatment of Dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials
9. Meibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell Transplantation
10. COVID-19 Vaccination May Not Increase Rates of Corneal Graft Rejection
11. Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study
12. Corneal Neurotization: A Novel Surgical Procedure for Neurotrophic Keratopathy
13. Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation
14. Ocular Surface Workup With Automated Noninvasive Measurements for the Diagnosis of Meibomian Gland Dysfunction
15. Deep Anterior Lamellar Keratoplasty: Current Status and Future Directions.
16. Corneal Neurotization: A Novel Surgical Procedure for Neurotrophic Keratopathy.
17. In Vivo Confocal Microscopy Morphometric Analysis of Meibomian Glands in Patients With Graves Ophthalmopathy.
18. Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.